# US Phase III Study of APD421 in PONV

> **NCT01991860** · PHASE3 · COMPLETED · sponsor: **Acacia Pharma Ltd** · enrollment: 364 (actual)

## Conditions studied

- PONV

## Interventions

- **DRUG:** APD421- Amisulpride for IV injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01991860
- **Lead sponsor:** Acacia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01991860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01991860, "US Phase III Study of APD421 in PONV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01991860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*